Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Files IP Suit Against MDS, Life Technologies

NEW YORK (GenomeWeb News) - PerkinElmer this week filed a patent infringement suit against MDS, its MDS Analytcial Technologies business, and Life Technologies alleging infringement of claims in five US patents held by PerkinElmer.

The suit, which was filed earlier this week in the US District Court for the District of Massachusetts, claims that the MDS Analytical Technologies/Life Technologies joint venture is infringing the patents through sales of the JV's QSTAR line of mass spectrometers.

The patents held by PerkinElmer -- US Nos. 5,962,851; 5,652,427; 6,188,066; 6,020,586; 6,011,259 -- cover a multipole ion guide for mass spectrometry and an ion storage time-of-flight mass spectrometer. PerkinElmer claims in the suit that it informed the defendants of the patents on Sep. 2, 2009. It believes the MDS/Life Tech JV is infringing claims in the patents as well as inducing others to infringe those patents through the sale of the QSTAR products.

PerkinElmer has asked the court to declare that the defendants have infringed the patents, to enjoin them from further sales of allegedly infringing products, and to pay treble damages for willful infringement.

This suit follows a recent legal action taken by PerkinElmer in Canada last month seeking to block MDS' pending sale of a joint venture between the two firms to Danaher, as part of Danaher's agreement to buy MDS Analytical Technologies. In a notice of application filed with the Ontario Superior Court of Justice, PerkinElmer seeks alternatives to providing its consent to the sale of the Analytical Technologies business.

At the JP Morgan Healthcare Conference last week, PerkinElmer CEO Robert Friel declined to comment on the dispute, but said that the firm wants its joint venture to stay with MDS and not be "outsourced to Danaher."

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.